(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid

C57H94N2O17 — CID 75204096

IUPAC(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid
SMILESCCC1CC(C(=O)O[C@@H]2C[C@@H]3C[C@@H](N)CC[C@]3(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@H]4[C@H](C)CCC(=O)OC)[C@H]23)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1OC1OC(C)C(O)C(O)C1O
InChIInChI=1S/C57H94N2O17/c1-8-32-23-33(53(69)73-39-26-34-25-35(58)18-20-56(34,5)38-19-21-57(6)36(15-16-37(57)44(38)39)28(2)14-17-43(62)70-7)24-40(50(32)76-55-49(66)48(65)46(63)29(3)71-55)74-54-45(59-30(4)61)51(47(64)42(27-60)75-54)72-41(52(67)68)22-31-12-10-9-11-13-31/h28-29,31-42,44-51,54-55,60,63-66H,8-27,58H2,1-7H3,(H,59,61)(H,67,68)/t28-,29?,32?,33?,34+,35+,36+,37+,38+,39-,40-,41+,42-,44+,45-,46?,47+,48?,49?,50-,51-,54-,55?,56+,57-/m1/s1
InChIKeyMRUBNXNREXETTG-DJKDWJCXSA-N
MW1079.38 g/mol
LogP4.51
Rot. Bonds18

About (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid

(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid (PubChem CID 75204096) has the molecular formula C57H94N2O17 and a molecular weight of 1079.38 g/mol. Its IUPAC name is (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid.

Molecular Properties

Compound Name(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid
PubChem CID75204096
Molecular FormulaC57H94N2O17
Molecular Weight1079.38 g/mol
Exact Mass1078.66
IUPAC Name(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid
SMILESCCC1CC(C(=O)O[C@@H]2C[C@@H]3C[C@@H](N)CC[C@]3(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@H]4[C@H](C)CCC(=O)OC)[C@H]23)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1OC1OC(C)C(O)C(O)C1O
InChIInChI=1S/C57H94N2O17/c1-8-32-23-33(53(69)73-39-26-34-25-35(58)18-20-56(34,5)38-19-21-57(6)36(15-16-37(57)44(38)39)28(2)14-17-43(62)70-7)24-40(50(32)76-55-49(66)48(65)46(63)29(3)71-55)74-54-45(59-30(4)61)51(47(64)42(27-60)75-54)72-41(52(67)68)22-31-12-10-9-11-13-31/h28-29,31-42,44-51,54-55,60,63-66H,8-27,58H2,1-7H3,(H,59,61)(H,67,68)/t28-,29?,32?,33?,34+,35+,36+,37+,38+,39-,40-,41+,42-,44+,45-,46?,47+,48?,49?,50-,51-,54-,55?,56+,57-/m1/s1
InChIKeyMRUBNXNREXETTG-DJKDWJCXSA-N
XLogP4.51
TPSA292.32 Ų
H-Bond Donors8
H-Bond Acceptors17
Rotatable Bonds18
Heavy Atoms76
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001079.38
LogP ≤ 54.51
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1017

Analyze (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid?
The IUPAC name of (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid (CID 75204096) is (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid.
What is the SMILES notation for (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid?
The canonical SMILES for (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid is CCC1CC(C(=O)O[C@@H]2C[C@@H]3C[C@@H](N)CC[C@]3(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@H]4[C@H](C)CCC(=O)OC)[C@H]23)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1OC1OC(C)C(O)C(O)C1O.
What is the InChIKey of (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid?
The InChIKey is MRUBNXNREXETTG-DJKDWJCXSA-N. The full InChI is InChI=1S/C57H94N2O17/c1-8-32-23-33(53(69)73-39-26-34-25-35(58)18-20-56(34,5)38-19-21-57(6)36(15-16-37(57)44(38)39)28(2)14-17-43(62)70-7)24-40(50(32)76-55-49(66)48(65)46(63)29(3)71-55)74-54-45(59-30(4)61)51(47(64)42(27-60)75-54)72-41(52(67)68)22-31-12-10-9-11-13-31/h28-29,31-42,44-51,54-55,60,63-66H,8-27,58H2,1-7H3,(H,59,61)(H,67,68)/t28-,29?,32?,33?,34+,35+,36+,37+,38+,39-,40-,41+,42-,44+,45-,46?,47+,48?,49?,50-,51-,54-,55?,56+,57-/m1/s1.
What are the key properties of (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid?
(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid has a molecular weight of 1079.38 g/mol, XLogP of 4.51, 18 rotatable bonds, 8 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R)-5-[[(3S,5S,7R,8R,9S,10S,13R,14S,17S)-3-amino-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxycarbonyl]-3-ethyl-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid is sourced from PubChem (CID 75204096), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).